Core Viewpoint - The company has clarified the astaxanthin content specifications for its 3000-ton astaxanthin project, indicating that it produces according to customer demand, with two main specifications of 1-1.5% and above 1.5% [1] Company Summary - The company, Jinhe Biological (002688.SZ), responded to an investor inquiry regarding the astaxanthin content in its project [1] - The astaxanthin content is categorized into two specifications based on customer requirements: 1-1.5% and above 1.5% [1]

Core Points - Jinhe Biological Technology Co., Ltd. has received approval for its feed additive product, red yeast, from the Inner Mongolia Agricultural and Animal Husbandry Department [2][3] - Astaxanthin, a carotenoid with strong antioxidant properties, has significant application potential in health foods, aquaculture, pharmaceuticals, and cosmetics [2] - The company has established an annual production capacity of 3,000 tons of astaxanthin, indicating its commitment to research and innovation in synthetic biology applications [3] Summary by Category - **Product Approval** - Jinhe Biological has obtained the product approval number for its feed additive, red yeast, enhancing its product portfolio [2][3] - **Astaxanthin Properties** - Astaxanthin is noted for its antioxidant capacity, being 10 times more potent than beta-carotene, 200 times more than lutein, and 550 times more than vitamin E [2] - The main sources of astaxanthin include natural extraction, chemical synthesis, and microbial fermentation, with fermentation being the most viable method due to safety and stability [2] - **Commercial Value** - Red yeast is recognized for its rapid growth cycle, short fermentation period, ease of cultivation, and ability to utilize various carbon sources, making it commercially valuable [2] - The approval of the red yeast product is expected to enhance Jinhe Biological's operational performance and market competitiveness [3]

Core Viewpoint - The company has received approval for its feed additive product, red yeast, which is expected to enhance its product portfolio and market competitiveness, driven by the increasing demand for natural astaxanthin in various industries [2][3]. Group 1: Product Approval and Market Potential - The company has obtained the product approval number for its feed additive, red yeast, from the Inner Mongolia Agricultural and Animal Husbandry Department [2]. - Astaxanthin, a carotenoid with strong antioxidant properties, has a market value of $3.7 billion in 2022 and is projected to reach $11 billion by 2032 [2]. - The company has a production project with an annual capacity of 3,000 tons of astaxanthin, indicating significant production capabilities [2]. Group 2: Advantages of Red Yeast - Red yeast is recognized for its rapid growth cycle, short fermentation period, ease of cultivation, and ability to utilize various carbon sources, making it commercially valuable [3]. - The approval of the red yeast feed additive is expected to enrich the company's product structure and positively impact its operational performance and market competitiveness [3].

Core Viewpoint - The company has received approval for its feed additive product, red yeast, which is expected to enhance its product portfolio and market competitiveness, although it is not anticipated to significantly impact the company's financial performance for the current year [1]. Group 1: Product Approval Details - The product name is red yeast, with the approval number being 蒙饲添字（2025）090001, issued by the Inner Mongolia Agricultural and Animal Husbandry Department on September 15, 2025 [1]. - The product adheres to the standard Q/JHSW 253-2025 [1]. Group 2: Impact on the Company - The approval of the red yeast feed additive is a result of the company's ongoing commitment to research and development, particularly in the application of synthetic biology [1]. - The company has established a project with an annual production capacity of 3,000 tons of astaxanthin, a metabolite produced during the fermentation of red yeast [1]. - The new product approval is expected to positively influence the company's operational performance and market competitiveness [1].

Core Viewpoint - Jinhe Biological has received approval for its feed additive product, red yeast, from the Inner Mongolia Autonomous Region's Agricultural and Animal Husbandry Department [2] Group 1 - The company announced on the evening of November 3 that it has obtained the product approval number for its feed additive [2] - The approval signifies a regulatory milestone for the company's product development in the feed additive sector [2]

Core Insights - The animal health sector experienced a decline of 0.35% on November 3, with Reap Bio leading the losses [1] - The Shanghai Composite Index closed at 3976.52, up 0.55%, while the Shenzhen Component Index closed at 13404.06, up 0.19% [1] Stock Performance Summary - Hai Li Biological (603718) closed at 7.02, up 2.03% with a trading volume of 101,600 shares and a turnover of 70.93 million yuan [1] - Shen Lian Biological (688098) closed at 11.36, up 1.43% with a trading volume of 133,100 shares and a turnover of 150 million yuan [1] - Yong Shun Biological (920729) closed at 10.09, up 1.00% with a trading volume of 23,800 shares and a turnover of 24.09 million yuan [1] - The worst performer was Reap Bio (300119), which closed at 21.01, down 2.51% with a trading volume of 103,300 shares and a turnover of 219 million yuan [2] Capital Flow Analysis - The animal health sector saw a net outflow of 35.26 million yuan from institutional investors, while retail investors had a net inflow of 26.79 million yuan [2] - The main capital inflow was observed in Shen Lian Biological, with a net inflow of 4.03 million yuan from institutional investors [3] - Conversely, Reap Bio experienced a net outflow of 1.29 million yuan from institutional investors [3]

Core Viewpoint - The company Jinhe Biotechnology (002688.SZ) has received approval for its feed additive product, red yeast, from the Inner Mongolia Autonomous Region's Department of Agriculture and Animal Husbandry [1] Group 1 - The company has developed a feed additive called red yeast, which has now been granted a product approval number [1]

Core Viewpoint - The company Jinhe Biotechnology (002688.SZ) has received approval for its feed additive product, red yeast, from the Inner Mongolia Agricultural and Animal Husbandry Department, which is expected to enhance its product portfolio and market competitiveness [1] Group 1: Product Development - The approved feed additive, red yeast, is a metabolite produced during the fermentation process, which includes astaxanthin [1] - The company has established a project with an annual production capacity of 3,000 tons of astaxanthin [1] Group 2: Research and Innovation - The approval of the feed additive product is a result of the company's ongoing emphasis on research and innovation [1] - The company is accelerating the application and layout of synthetic biology in its industry [1] Group 3: Business Impact - The approval is expected to positively contribute to the company's operational performance and market competitiveness [1] - It is anticipated that this approval will not have a significant impact on the company's operating performance for the current year [1]

Core Viewpoint - The company Jinhe Biotechnology (002688.SZ) has received approval for its feed additive product, red yeast, from the Inner Mongolia Autonomous Region's Department of Agriculture and Animal Husbandry [1] Group 1 - The company has been granted the product approval number for its developed feed additive, red yeast [1]

Core Viewpoint - The company has received approval for its feed additive product, red yeast, which is expected to enhance its product portfolio and competitiveness, although it is not anticipated to have a significant impact on this year's performance [1] Group 1: Product Approval - The company has obtained the product approval number for its feed additive red yeast from the Inner Mongolia Agricultural and Animal Husbandry Department, with the approval date set for September 15, 2025 [1] - The approval number is 蒙饲添字（2025）090001, indicating regulatory compliance for the new product [1] Group 2: Production Capacity - The company has established a production project with an annual capacity of 3,000 tons for astaxanthin, a metabolite of red yeast [1] - This production capacity is expected to support the company's growth and diversification in its product offerings [1] Group 3: Financial Impact - The approval of the new product is expected to enrich the company's product structure and enhance its competitiveness [1] - However, it is noted that the approval will not have a major impact on the company's performance for the current fiscal year [1]